|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 124, Issue 18 3511-3523, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
HM Stern, J Lin-Jones and SD Hauschka
University of Washington, Department of Biochemistry, Seattle, 98195, USA.
Development of the myotome within somites depends on unknown signals from the neural tube. The present study tested the ability of basic fibroblast growth factor (bFGF), transforming growth factor-beta1 (TGF-beta1) and dorsalin-1 (dsl-1) to promote myogenesis in stage 10-14 chick paraxial mesoderm utilizing 72 hour explant cultures. Each of these factors alone and the combination of bFGF with dsl-1 had limited to no myogenic-promoting activity, but the combination of bFGF with TGF-beta1 demonstrated a potent dose-dependent effect. In addition, bFGF enhanced the survival/proliferation of somite cells. 98% of stage 10-11 caudal segmental plate explants treated with bFGF plus TGF-beta1, exhibited myosin heavy chain (MHC)-positive cells (avg.=60 per explant), whereas only 15% of similarly treated somites responded with an average of 5 MHC-positive cells. Thus at stage 10-11, there are rostrocaudal differences in myogenic responsiveness with the caudal (more 'immature') paraxial mesoderm being more myogenically responsive to these factors than are somites. It was also discovered that 17% of stage 10-11 caudal segmental plate explants exhibited several MHC-positive cells even when cultured without added growth factors, further demonstrating a different myogenic potential of the caudal paraxial mesoderm. Stage 13-14 paraxial mesoderm also exhibited a myogenic response to bFGF/TGF-beta1 but, unlike stage 10-11 embryos, both somites and segmental plate exhibited a strong response. A two-step mechanism for the bFGF/TGF-beta1 effect is suggested by the finding that only TGF-beta1 was required during the first 12 hours of culture, whereas bFGF plus a TGF-beta-like factor were required for the remainder of the culture. The biological relevance of the findings with bFGF is underscored by the observation that a monoclonal antibody to bFGF inhibited myogenic signaling from the dorsal neural tube. However, a monoclonal antibody that can neutralize the three factors TGF-beta1, TGF-beta2 and TGF-beta3 did not block myogenic signals from the neural tube, raising the possibility that another TGF-beta family member may be involved in vivo.
This article has been cited by other articles:
![]() |
J. Gerhart, C. Neely, J. Elder, J. Pfautz, J. Perlman, L. Narciso, K. K. Linask, K. Knudsen, and M. George-Weinstein Cells that express MyoD mRNA in the epiblast are stably committed to the skeletal muscle lineage J. Cell Biol., August 9, 2007; 178(4): 649 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Geetha-Loganathan, S. Nimmagadda, R. Huang, B. Christ, and M. Scaal Regulation of ectodermal Wnt6 expression by the neural tube is transduced by dermomyotomal Wnt11: a mechanism of dermomyotomal lip sustainment Development, August 1, 2006; 133(15): 2897 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. J. Roelen, O. S. Cohen, M. K. Raychowdhury, D. N. Chadee, Y. Zhang, J. M. Kyriakis, A. A. Alessandrini, and H. Y. Lin Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-{beta}-induced nuclear accumulation Am J Physiol Cell Physiol, October 1, 2003; 285(4): C823 - C830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Venters and C. P. Ordahl Persistent myogenic capacity of the dermomyotome dorsomedial lip and restriction of myogenic competence Development, March 10, 2003; 129(16): 3873 - 3885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Fisher, H. V. Isaacs, and M. E. Pownall eFGF is required for activation of XmyoD expression in the myogenic cell lineage of Xenopus laevis Development, March 5, 2003; 129(6): 1307 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meriane, P. Roux, M. Primig, P. Fort, and C. Gauthier-Rouvière Critical Activities of Rac1 and Cdc42Hs in Skeletal Myogenesis: Antagonistic Effects of JNK and p38 Pathways Mol. Biol. Cell, August 1, 2000; 11(8): 2513 - 2528. [Abstract] [Full Text] |
||||
![]() |
M Schmidt, M Tanaka, and A Munsterberg Expression of (beta)-catenin in the developing chick myotome is regulated by myogenic signals Development, January 10, 2000; 127(19): 4105 - 4113. [Abstract] [PDF] |
||||
![]() |
A. Borycki, J Li, F Jin, C. Emerson, and J. Epstein Pax3 functions in cell survival and in pax7 regulation Development, January 4, 1999; 126(8): 1665 - 1674. [Abstract] [PDF] |
||||
![]() |
K. Krieglstein, P. Henheik, L. Farkas, J. Jaszai, D. Galter, K. Krohn, and K. Unsicker Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-beta for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons J. Neurosci., December 1, 1998; 18(23): 9822 - 9834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. de Caestecker, W. T. Parks, C. J. Frank, P. Castagnino, D. P. Bottaro, A. B. Roberts, and R. J. Lechleider Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases Genes & Dev., June 1, 1998; 12(11): 1587 - 1592. [Abstract] [Full Text] |
||||
![]() |
A Rawls, M. Valdez, W Zhang, J Richardson, W. Klein, and E. Olson Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice Development, January 7, 1998; 125(13): 2349 - 2358. [Abstract] [PDF] |
||||